Kidney Cancer Drug Shows Promise in Early Trial
93 percent had tumor growth controlled for median of more than 8 months, researchers reportContinue Reading
93 percent had tumor growth controlled for median of more than 8 months, researchers reportContinue Reading
Conference organizers call for worldwide research partnershipsContinue Reading
Woman had no travel-related risk factors, CDC saysContinue Reading
The goal: to spot early signs of concussion-related head traumaContinue Reading
Problem linked to changes in amount of fluid around the brain and spinal cord, researchers sayContinue Reading
Used with a smartphone app, it’s designed to offer information about your health, inventors sayContinue Reading
Still, the likelihood of developing postoperative Guillain-Barre syndrome remains slight, researchers sayContinue Reading
No, eating it doesn’t make you sleepy, the skin isn’t all bad and other common misconceptionsContinue Reading
Findings underscore need for continuing evaluation after prenatal exposureContinue Reading
Public invited to comment on draft recommendation, which is the same as one in place since the 1990sContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.